Some aspects of the application of new medical technologies in reproduction, therapy (human) and genetic modification (human, plant, animal) through the prism of regulatory provisions and recognized ethical rules (guidelines) in stem cell research and biomedical research in India in the context of intellectual property rights protection

This article aims to denote some facets of the current state of legal regulation and ethical problems of application of new medical technologies in reproduction, therapy (human) and genetic modification (human, plant, animal) in the course of stem cell research and biomedical research in the context of intellectual property rights protection and based on the materials of a number of normative acts and documents and ethical guidelines of one of the BRICS countries - India. In this format, the article analyzes the provisions of Indian approaches that create patterns of application of new medical technologies, the potential and ethical and legal basis for such development on the basis of current views of the doctrine and provisions of legislative and other acts studied in this article, based on analytical reflections on information drawn from sources and literature from the list of sources and literature. The relevance of this research is due to the fact that a number of approaches to legislation and ethical guidelines under study are new and could not be considered in the studies of an earlier period. Thus, this study serves to fill this gap. The author's results are presented in the light of the identified state interest in delineating the boundaries of (not) permissible use of new medical technologies in the field of human reproduction and therapy, genetic modification of humans, animals and plants, both from the position of legal and ethical restrictions, permits and prohibitions, and from the position of implementing the provisions of the current legislation of India on the protection of intellectual property rights. The result of this interest is the simultaneous operation of regulations and non-binding codes of ethics (guidelines) in the field of bio-medical research and stem cell research, which focus public attention on some issues of the controversial application of new medical technologies with an emphasis on the research component based on a liberal model of the relationship between law and bioethics, while the Indian law prohibits patenting the results of biomedical research. The theoretical and practical significance of the results obtained is determined by the fact that Russian readers will be provided with up-to-date scientific information about the state of Indian legislation and doctrine, and other ideas in the field under study, which in practical terms will contribute to understanding the gap (or lack thereof) in the achievements in this field of Russian and foreign researchers and practitioners in terms of their implications at the level of practice and legislation.

science, scientific information, scientific research, India, BRICS, assisted reproductive technologies, IVF, reproductive and therapeutic gene editing, embryos, stem cells, humans, plants, animals, discoveries, inventions, ethics, medicine